Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers.
In Finland, most cases of shigellosis are related to travel abroad. Antimicrobial drug resistance of 1814 Shigella strains isolated from Finnish patients during 1990-2005 was studied using discs of 12 antimicrobial agents. Since 2000, the E-test has been performed to determine ciprofloxacin minimum inhibitory concentrations of nalidixic acid-resistant isolates. The proportion of multi-resistant strains (resistant to >or =4 antimicrobials) was highest among isolates from China and India, but is increasing significantly in other parts of Asia. Resistance to nalidixic acid has become common among the strains from the Far East, and the first isolates also resistant to ciprofloxacin were detected during 2004-2005. All the ciprofloxacin-resistant isolates belonged to the S. flexneri 2a serotype. All the nalidixic acid-resistant S. flexneri strains had reduced susceptibility to ciprofloxacin, whereas 23% of the nalidixic acid-resistant S. sonnei strains were still completely susceptible to ciprofloxacin.
Haukka
K
K
Enteric Bacteria Laboratory, Department of Bacterial and Inflammatory Diseases, National Public Health Institute KTL, Helsinki, Finland.
Siitonen
A
A
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D021821:Communicable Diseases, Emerging / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D004405:Dysentery, Bacillary / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D005387:Finland / Q000453:epidemiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D012760:Shigella / Q000145:classification* / Q000187:drug effects / Q000302:isolation & purification; D014195:Travel
D000900:Anti-Bacterial Agents